Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP754390.RAMpRHZY63YkqkfT5tunFnho5fpk4DKgtF2C5M34BK8KQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP754390.RAMpRHZY63YkqkfT5tunFnho5fpk4DKgtF2C5M34BK8KQ130_assertion type Assertion NP754390.RAMpRHZY63YkqkfT5tunFnho5fpk4DKgtF2C5M34BK8KQ130_head.
- NP754390.RAMpRHZY63YkqkfT5tunFnho5fpk4DKgtF2C5M34BK8KQ130_assertion description "[MAL methylation status may therefore serve as a marker of platinum sensitivity while MAL protein may be a target for development of novel therapies aimed at enhancing sensitivity to platinum-based drugs in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754390.RAMpRHZY63YkqkfT5tunFnho5fpk4DKgtF2C5M34BK8KQ130_provenance.
- NP754390.RAMpRHZY63YkqkfT5tunFnho5fpk4DKgtF2C5M34BK8KQ130_assertion evidence source_evidence_literature NP754390.RAMpRHZY63YkqkfT5tunFnho5fpk4DKgtF2C5M34BK8KQ130_provenance.
- NP754390.RAMpRHZY63YkqkfT5tunFnho5fpk4DKgtF2C5M34BK8KQ130_assertion SIO_000772 19642140 NP754390.RAMpRHZY63YkqkfT5tunFnho5fpk4DKgtF2C5M34BK8KQ130_provenance.
- NP754390.RAMpRHZY63YkqkfT5tunFnho5fpk4DKgtF2C5M34BK8KQ130_assertion wasDerivedFrom befree-2016 NP754390.RAMpRHZY63YkqkfT5tunFnho5fpk4DKgtF2C5M34BK8KQ130_provenance.
- NP754390.RAMpRHZY63YkqkfT5tunFnho5fpk4DKgtF2C5M34BK8KQ130_assertion wasGeneratedBy ECO_0000203 NP754390.RAMpRHZY63YkqkfT5tunFnho5fpk4DKgtF2C5M34BK8KQ130_provenance.